MENOPAUSE AND DRY MOUTH

-

MENOPAUSE AND DRY MOUTH




Dry mouth, or xerostomia, is a common concern in menopausal women, and the consequences of dry mouth can lead to dental and other health issues if not addressed.

 Several studies have investigated whether menopause leads to a measurable decrease in saliva production. Some research suggests an apparent reduction in both stimulated and unstimulated saliva among menopausal women, which aligns with increased reports of dry mouth. 

Yet other studies have found inconsistent results, suggesting that not every woman experiences a drop in saliva output. Still, dry mouth remains a common condition and can significantly affect the quality of life for many (Minicucci et al., Australian Dental Journal; Mahesh et al., Journal of Clinical and Diagnostic Research; Mojabi et al., Frontiers in Dentistry).

The causes are complex. Beyond hormones, factors such as stress (as indicated by higher levels of salivary cortisol) and changes in calcium and phosphate metabolism may contribute to the sensation of dry mouth during menopause. There is also evidence that xerostomia can harm oral health, increasing the risk of cavities, gum disease, and oral infections (Agha-Hosseini et al., Gerodontology; Jacob et al., Journal of Mid-life Health).

In short, dry mouth is a frequent and sometimes severe complaint during menopause. Hormonal changes mainly drive it, but other physical and psychological factors often worsen it. Regular dental visits and consistent oral care are recommended to help manage symptoms and protect oral health during this stage of life. If symptoms persist with good oral care, consult your dentist or physician for guidance.

Comments

Post a Comment

Popular posts from this blog

B12 MAY HELP PREVENT ALZHEIMER'S DISEASE.

-
Image
  B12 MAY HELP PREVENT ALZHEIMER'S DISEASE. Worms don't wiggle when they have Alzheimer's disease. Yet something helped worms with the disease hold onto their wiggle in Professor Jessica Tanis's lab at the University of Delaware. In solving the mystery, Tanis and her team have yielded new clues into the potential impact of diet on Alzheimer's, the dreaded degenerative brain disease afflicting more than 6 million Americans. A few years ago, Tanis and her team began investigating factors affecting the onset and progression of Alzheimer's disease. They were doing genetic research with  C. elegans , a tiny soil-dwelling worm subject of numerous studies. Expression of amyloid-beta, a toxic protein implicated in Alzheimer's disease, paralyzes worms within 36 hours of reaching adulthood. While the worms in one petri dish in Tanis's lab were rendered completely immobile, the worms of the same age in the adjacent petri dish still had their wiggle, documented as ...
Read more

EXTREME HEAT MAY NEGATIVELY IMPACT COGNITIVE HEALTH

-
Image
  EXTREME HEAT MAY NEGATIVELY IMPACT COGNITIVE HEALTH          July 2023 was the hottest month, with cities like Phoenix experiencing record-breaking heat waves for weeks. A new study finds that ongoing extreme heat can worsen cognitive decline among vulnerable groups -- particularly Black older adults and those living in poor neighborhoods. "Our research finds that cumulative exposure to extreme heat can undermine cognitive health, but it does so unequally across the population," said Eunyoung Choi, a postdoctoral associate at the NYU School of Global Public Health and the first author of the study, published in the  Journal of Epidemiology and Community Health . Extreme heat is the leading cause of weather-related deaths in the U.S., claiming more lives each year than hurricanes, tornadoes, and lightning combined. Young children and older adults are particularly vulnerable to heat-related illnesses such as heat exhaustion and heat stroke. Recent stud...
Read more

Diabetes drugs may reduce the risk of Alzheimer’s.

-
Image
    Diabetes drugs may reduce the risk of Alzheimer’s. The study finds people taking the drugs have fewer biomarkers, slower cognitive decline. People taking certain drugs to lower blood sugar for type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer's disease compared to people with type 2 diabetes who are not taking the drugs and those without diabetes. The new study, published in the August 11, 2021, online issue of  Neurology , the medical journal of the American Academy of Neurology, also found people taking these drugs, called dipeptidyl peptidase-4 inhibitors, showed slower cognitive decline than people in the other two groups. In people with type 2 diabetes, the body no longer efficiently uses insulin to control blood sugar. Dipeptidyl peptidase-4 inhibitors, also known as gliptins, can be prescribed when other diabetes drugs do not work. They help control blood sugar when combined with diet and exercise. "People with diabetes have been shown to ...
Read more